CREDITACCNSECREDITACCESS GRAMEEN LIMITED· FinanceHighNeutral
Announced Tue, 28 Oct, 2025 · 18:15 IST

Q2 profit doubles sequentially, but half-year profit drops 83%

Pat Growth 25pctDebt Equity ThresholdResults View source PDFExplain this filing

CREDITACC · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-4.1%Reaction day
₹1469.90
prior close
₹1384.10
announcement price
After-mkt
timing
Nifty Smallcap 250market · index membership as recorded later (tracked since Jun 2026)+0.4%-4.5% vs market
Finance peers, median of 383sector · industry level+0.1%-4.2% vs sector

On the reaction day the stock moved 4.5 pts less than Nifty Smallcap 250 and 4.2 pts less than its Finance peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
+3.8
10m
+3.8
15m
+5.1
30m
+4.3
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-4.1+0.4-4.5+0.1-4.2
Next day
+0.6+0.4+0.2-0.1+0.6
2d
-4.0-0.2-3.8+0.0-4.0
3d
-4.3+0.5-4.8+0.0-4.3
4d
-6.0-0.2-5.9-0.7-5.3
5d
-9.0-1.6-7.3-1.9-7.1
1w
-3.8-1.9-1.9-1.9-2.0
15d
-9.7-2.4-7.3-3.7-5.9
1m
-8.5-3.3-5.2-4.5-4.0
2m
-13.3-4.7-8.5-7.5-5.7
3m
-13.5-9.9-3.6-13.4-0.1
UpDownMarket · Nifty Smallcap 250Sector · Finance peers, median of 383Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

The board approved unaudited September 2025 results and proposed Sundaram and Srinivasan as joint auditor from FY2026-27, subject to shareholder approval. Q2 revenue rose 3.1% to Rs 1,508.35 crore, while net profit more than doubled to Rs 125.81 crore from Rs 60.19 crore. Half-year profit fell to Rs 186 crore from Rs 1,100.72 crore as impairment charges rose to Rs 1,097.52 crore. Debt-to-equity was 2.82 and operating cash flow stayed positive.

Likely market impact

Q2 profit doubled, but half-year profit fell 83% on higher impairment charges. Debt-to-equity of 2.82 adds risk, leaving the stock outlook mixed.